Clinical Trial Update: A Trial of Cilostazol in Patients With Mild Cognitive Impairment (COMCID) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating cilostazol for mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

Sponsor: National Cerebral and Cardiovascular Center, Japan | Conditions: Mild Cognitive Impairment | Phase 2 | Status: COMPLETED